Q2 EPS Estimates for Henry Schein Lowered by Zacks Research

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Equities research analysts at Zacks Research decreased their Q2 2025 earnings estimates for shares of Henry Schein in a research note issued on Wednesday, April 2nd. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $1.19 for the quarter, down from their prior forecast of $1.21. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. Zacks Research also issued estimates for Henry Schein's Q2 2025 earnings at $1.19 EPS, FY2025 earnings at $4.83 EPS, FY2025 earnings at $4.83 EPS, Q1 2026 earnings at $1.31 EPS, Q1 2026 earnings at $1.31 EPS, Q2 2026 earnings at $1.35 EPS, Q2 2026 earnings at $1.35 EPS, Q4 2026 earnings at $1.38 EPS, Q4 2026 earnings at $1.38 EPS, FY2026 earnings at $5.29 EPS, FY2026 earnings at $5.29 EPS, FY2027 earnings at $5.69 EPS and FY2027 earnings at $5.69 EPS.

Several other brokerages have also commented on HSIC. Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and raised their price objective for the stock from $69.00 to $84.00 in a report on Monday, January 6th. UBS Group dropped their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Barrington Research reaffirmed an "outperform" rating and issued a $90.00 price target on shares of Henry Schein in a research note on Wednesday, February 26th. Jefferies Financial Group raised their price objective on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. Finally, Wells Fargo & Company started coverage on shares of Henry Schein in a research report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 target price on the stock. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Henry Schein presently has an average rating of "Moderate Buy" and an average target price of $81.10.

Henry Schein Trading Up 2.8 %

Shares of NASDAQ:HSIC traded up $1.78 on Friday, hitting $64.48. The company had a trading volume of 787,610 shares, compared to its average volume of 1,590,355. The firm's 50-day simple moving average is $73.10 and its two-hundred day simple moving average is $72.40. The firm has a market capitalization of $8.01 billion, a price-to-earnings ratio of 26.68, a P/E/G ratio of 2.13 and a beta of 0.84. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein has a 1 year low of $60.60 and a 1 year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the business earned $0.66 earnings per share. The firm's revenue for the quarter was up 5.8% compared to the same quarter last year.

Institutional Trading of Henry Schein

A number of institutional investors have recently made changes to their positions in HSIC. Public Sector Pension Investment Board lifted its position in Henry Schein by 8.1% during the third quarter. Public Sector Pension Investment Board now owns 5,336 shares of the company's stock valued at $389,000 after purchasing an additional 400 shares during the period. Martingale Asset Management L P purchased a new stake in Henry Schein during the third quarter valued at $222,000. Investment Management Corp of Ontario bought a new position in Henry Schein in the third quarter valued at about $309,000. Quantinno Capital Management LP boosted its position in Henry Schein by 2.8% in the third quarter. Quantinno Capital Management LP now owns 58,533 shares of the company's stock worth $4,267,000 after purchasing an additional 1,591 shares during the last quarter. Finally, Stifel Financial Corp grew its stake in shares of Henry Schein by 1.2% during the 3rd quarter. Stifel Financial Corp now owns 1,122,455 shares of the company's stock valued at $81,827,000 after purchasing an additional 13,180 shares during the period. Hedge funds and other institutional investors own 96.62% of the company's stock.

Insider Transactions at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.